학술논문

A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With EGFR-Mutant NSCLC
Document Type
Article
Source
In JTO Clinical and Research Reports September 2022 3(9)
Subject
Language
ISSN
2666-3643